Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
UGI
UGI
$8.23B
| $4.09M | 0.01% |
117,501
-229,899
| -66% | -$8.03M |
|
|
SPPI
1452
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $4.09M | 0.01% |
683,560
-1,565,669
| -70% | -$10.9M |
|
|
GCI
1453
DELISTED
Gannett Co., Inc
GCI
| $4.08M | 0.01% |
+277,185
| New | +$3.63M |
|
1454
O-I Glass
OI
$1.15B
| $4.08M | 0.01% |
196,889
-1,413,863
| -88% | -$30.1M |
|
1455
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
| $4.08M | 0.01% |
60,780
+56,554
| +1,338% | +$4.02M |
|
|
SIGM
1456
DELISTED
Sigma Designs Inc
SIGM
| $4.08M | 0.01% |
591,463
+58,928
| +11% | +$570K |
|
1457
Synopsys
SNPS
$78.3B
| $4.03M | 0.01% |
+87,213
| New | +$4.28M |
|
|
BECN
1458
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $4.02M | 0.01% |
+123,844
| New | +$4.23M |
|
|
SEP
1459
CALL
DELISTED
Spectra Engy Parters Lp
SEP
| $4.02M | 0.01% |
100,000
+59,800
| +149% | +$2.8M |
|
1460
FS KKR Capital
FSK
$3.33B
| $4.01M | 0.01% |
107,480
-15,203
| -12% | -$612K |
|
1461
Cognex
CGNX
$10.1B
| $3.99M | 0.01% |
232,412
-32,660
| -12% | -$649K |
|
1462
LendingTree
TREE
$429M
| $3.98M | 0.01% |
42,788
+38,714
| +950% | +$3.92M |
|
|
EQM
1463
DELISTED
EQM Midstream Partners, LP
EQM
| $3.98M | 0.01% |
+60,000
| New | +$4.53M |
|
1464
Watts Water Technologies
WTS
$12.4B
| $3.98M | 0.01% |
75,321
+24,067
| +47% | +$1.28M |
|
1465
Belden
BDC
$4.57B
| $3.98M | 0.01% |
85,188
-156,697
| -65% | -$9.24M |
|
|
BFX
1466
DELISTED
BowFlex Inc.
BFX
| $3.96M | 0.01% |
264,252
+98,717
| +60% | +$1.77M |
|
|
CAMP
1467
DELISTED
CalAmp Corp.
CAMP
| $3.96M | 0.01% |
10,705
-618
| -5% | -$243K |
|
1468
United States Oil Fund
USO
$1.97B
| $3.96M | 0.01% |
33,712
-18,156
| -35% | -$2.23M |
|
|
PCL
1469
CALL
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $3.95M | 0.01% |
+100,000
| New | +$4.01M |
|
1470
Brady Corp
BRC
$4.41B
| $3.94M | 0.01% |
200,661
+169,905
| +552% | +$3.83M |
|
|
HUB.A
1471
DELISTED
HUBBELL INC CL-A
HUB.A
| $3.93M | 0.01% |
36,364
+6,291
| +21% | +$676K |
|
|
ECYT
1472
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $3.92M | 0.01% |
856,141
+71,734
| +9% | +$375K |
|
|
BNY
1473
CALL
Bank of New York Mellon
BNY
$111B
| $3.92M | 0.01% |
100,000
| – | – |
|
1474
AAR Corp
AIR
$5.45B
| $3.91M | 0.01% |
+206,227
| New | +$5.35M |
|
|
TOWR
1475
DELISTED
Tower International, Inc.
TOWR
| $3.9M | 0.01% |
164,279
+1,929
| +1% | +$49.2K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.